Xenon Pharmaceuticals Inc.
XENE
$55.00
-$0.78-1.40%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.38% | -47.62% | -43.56% | -39.77% | -33.32% |
| Total Depreciation and Amortization | -6.15% | -0.66% | 105.38% | 12.52% | 14.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.51% | 34.08% | 12.42% | 49.86% | 101.69% |
| Change in Net Operating Assets | 2,576.32% | -23.68% | -164.10% | -2,720.75% | 79.62% |
| Cash from Operations | -55.63% | -53.88% | -55.18% | -42.98% | -20.85% |
| Capital Expenditure | 69.66% | 74.02% | 46.67% | 47.21% | 18.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -190.75% | 30.18% | 249.23% | 285.88% | 224.31% |
| Cash from Investing | -192.21% | 32.12% | 246.46% | 279.94% | 220.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7,120.65% | 865.48% | -95.15% | -96.22% | -96.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 7,120.65% | 865.48% | -95.15% | -96.22% | -96.24% |
| Foreign Exchange rate Adjustments | 128.63% | 127.39% | -121.19% | 12.44% | -2,638.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 643.08% | 1,051.80% | 241.33% | -101.87% | 644.09% |